Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery

NCT02975661 is registered in ClinicalTrials.gov with Qidong Gaitianli Medicines Co., Ltd as lead sponsor.

NCT NCT02975661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02975661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry of Huaier Granule for Prevention of Recurrence and Metastasis of Gastrointestinal Cancer After Radical Surgery
Lead sponsor
Qidong Gaitianli Medicines Co., Ltd
Phase
Observational
Overall status
Unknown status
Start date
February 4, 2017
Completion date
February 29, 2024
Enrollment
740 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer